Company case study · 2 podcast episodes
Eli Lilly
Eli Lilly is a pharmaceutical company that is actively applying AI to drug development. It came up on 2 podcast episodes (My First Million) between December 18, 2025 and November 9, 2026.
At a glance
| Discussed on | 2 episodes: My First Million |
|---|---|
| First and latest | December 18, 2025 to November 9, 2026 |
| Revenue and traction | Eli Lilly's stock was noted to be up 35% over the year. |
| Category | E-commerce |
Figures and claims are as told on the episodes, summarized from the transcript. Check the date: they describe the company at the time it aired.
What My First Million said
What I’d build if I wanted to get rich with AI · aired November 9, 2026 · hosted by Sam Parr and Shaan Puri
Why it works
The company's significant investment in AI and computing resources allows it to innovate and improve drug development processes.
The playbook
Eli Lilly is leaning heavily into AI, akin to tech companies, to enhance their capabilities in drug development.
Also mentioned
The company aims to reduce the time and cost associated with bringing new drugs to market.
What My First Million said
The 2025 Milly Awards! · aired December 18, 2025 · hosted by Sam Parr and Shaan Puri
Why it works
Eli Lilly focuses on advanced research and development, particularly in drugs that address critical health issues, which positions it as a leader in the pharmaceutical industry.
Revenue and traction
Eli Lilly's stock was noted to be up 35% over the year.
The playbook
The company has embraced technology and innovation in drug development, including the use of AI.
Also mentioned
Eli Lilly has become the first pharmaceutical company to reach a trillion-dollar market valuation.